SMARCB1 and kidney neoplasm: SMARCB1-deficient RMC is a rare, difficult-to-treat kidney tumor with a uniformly poor prognosis that occurs in adolescents and young adults in association with sickle cell trait. Here, we report a case of RMC in a 25-year-old male.